Silicon Valley Bank Leads Group of Sponsors Funding LabCentral Ignite Programs to Support Underrepresented Life Sciences Entrepreneurs

Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health part of group sponsoring LabCentral Ignite’s 2023 Golden Ticket competition and fellowship program supporting diverse founders in the life sciences

Published on:
February 23, 2023

CAMBRIDGE, Mass., Feb. 23, 2023 — Silicon Valley Bank has assembled a diverse group of organizations, including Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, to sponsor LabCentral Ignite, a first-and-only-of-its-kind platform to address systemic racial, gender, and other underrepresentation in talent across the life sciences and biotech industry.

In addition to their banking, legal, accounting, and healthcare consulting expertise for the life sciences industry, the financial contribution from these sponsors will support Ignite’s entrepreneur programming, such as the LabCentral Ignite Golden Ticket competition and the accompanying Ignite Fellowship.

The LabCentral Ignite Golden Ticket contest was designed to support biotech entrepreneurs who identify as women, Black, Latinx, Indigenous, or other persons of color who are using innovative science to solve human health problems. Winners receive free access to LabCentral’s shared lab space in Cambridge. In addition, winners participate in a year-long Ignite Fellowship program that aims to supercharge their networks, connecting these entrepreneurs to top investors, partners, advisors, and mentors.

“As Ignite enters our third year, we remain dedicated to amplifying the voices and expanding opportunities for those who have historically been excluded from this industry so they can focus on changing the world through groundbreaking science. Thanks to the support of Silicon Valley Bank, Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, who believe in our mission, we can support more underrepresented entrepreneurs with the potential to significantly impact biotech and the life sciences,” said Gretchen Cook-Anderson, LabCentral Ignite’s Executive Director.

“At Silicon Valley Bank, we know that diverse perspectives and inclusive environments ignite new ideas and power innovation,” said Anton Xavier, Director, SVB Startup Banking. “The LabCentral Ignite program spotlights often overlooked communities in biotech and life sciences and creates opportunities to foster a culture of inclusion in the industry.”

The 2023 LabCentral Ignite Golden Ticket contest will launch later this year. Candidates will be reviewed based on the quality and potential impact of their science along with other standard selection criteria. A select number of finalists will receive access to coaching and will be invited to present at a pitch event in September during Global Biotech Week, which draws industry professionals and investors to life sciences events around the world. Following the pitch contest, the winning companies will be awarded Ignite Golden Tickets.

About LabCentral Ignite

The growing Ignite platform is dedicated to developing equity, inclusion, and opportunity within the life sciences field. Through a range of equity-driven programs and a growing member network of industry, startups, higher education, and nonprofits, Ignite connects underrepresented students, talent and innovators to academic, technical skills-building, mentoring, job placement, and board and leadership preparation opportunities that fuel biotech diversity and inclusively transform careers. More information is available at

About LabCentral

LabCentral is a network of laboratory spaces and scientific communities, purposed designed to jumpstart the launch of promising early-stage life-sciences companies. Providing first-class operational support, curated events and programming, and access to a diverse network of sponsors, LabCentral prepares entrepreneurs and scientists to accelerate scientific innovation in service of human health. More information is available at

Related news

Publications September 15, 2023
Leveraging a Virtual Site to Boost Diversity and Enrollment
The client’s study aimed to assess the sensitivity and specificity of a novel diagnostic test for colorectal cancer in a large population representative of the diversity in the US.(...)
Blog September 6, 2023
Execution: How Biotechs Can Plan and Run Successful Clinical Trials
Biotech experts Joris Pezzini and Chris Rao answer questions about the challenges of executing a successful clinical trial.
News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma
Events August 16, 2023
We are excited to attend, speak at, and sponsor BioSpain, one of the leading conferences in the European biotechnology field.
Biotech Spain
Events July 25, 2023
BIO-Europe Autumn
Connect with Alira Health at BIO-Europe and discover how we can assist you at every stage of your clinical development to achieve your goals.
Biostatistics Biotech EU
Blog July 24, 2023
What EU Companies Need to Know about the U.S. Inflation Reduction Act
We spoke with our inhouse experts to learn about the significance of the US Inflation Reduction Act for EU pharma and biotech companies.
Biotech Drug Development Pharma
Blog July 17, 2023
Fundraising: Best Practices in a Challenging Environment
Experts Joris Pezzini and Dan Pastore discuss the importance of fundraising, one of the three required jobs for successful biotech leaders.
Biotech Funding
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.